Journal profile · Medicine-Pulmonary and Respiratory Medicine
Atemwegs- und Lungenkrankheiten
ISSN 0341-3055 · Dustri-Verlag Dr. Karl Feistle
Atemwegs- und Lungenkrankheiten: subscription journal; 76 articles in 2025; indexed in Scopus.
Scope
Aims, scope and focus
Atemwegs- und Lungenkrankheiten is published by Dustri-Verlag Dr. Karl Feistle. By OpenAlex counts of its recent articles, its largest topics are Chronic Obstructive Pulmonary Disease (COPD) Research, Asthma and respiratory diseases and Respiratory Support and Mechanisms, together about 43.6% of its articles. Its main subfields are Pulmonary and Respiratory Medicine and Physiology. (generated from OpenAlex topic counts and CAS ranking data)
Research area (LetPub): Medicine-Pulmonary and Respiratory Medicine
Main research topics OpenAlex counts of recent articles; shares are approximate
- Chronic Obstructive Pulmonary Disease (COPD) ResearchMedicine21.1%
- Asthma and respiratory diseasesMedicine16%
- Respiratory Support and MechanismsMedicine6.6%
- Interstitial Lung Diseases and Idiopathic Pulmonary FibrosisMedicine5.8%
- Obstructive Sleep Apnea ResearchMedicine5.1%
- Lung Cancer Diagnosis and TreatmentMedicine4.2%
- Occupational exposure and asthmaMedicine3.1%
- Smoking Behavior and CessationMedicine3.1%
Rankings & indexing
CAS ranking and database indexing
CAS Journal Ranking
CAS Journal Ranking, upgraded edition (March 2025)Not covered
Not covered by this edition.
CAS Xinrui Journal Ranking (March 2026)Not covered
Not covered by this edition.
CAS Journal Ranking, previous upgraded edition (December 2023)Not covered
Not covered by this edition.
CiteScore quartiles (Scopus, June 2026 release)
| Subject | Quartile | Rank | Percentile |
|---|---|---|---|
| Pulmonary and Respiratory Medicine | Q4 | 161/165 | 2nd |
Scopus ranks journals by CiteScore within each subject: the 75th percentile and above is Q1, then a quartile every 25 points. A different system from the CAS zones.LetPub
Database indexing
ScopusLetPub
International journal early-warning lists: not listed in any editionLetPub
Editions, and major and minor categories, are shown separately and never merged into one zone; check which edition your institution uses before you submit or report.
Metrics
Impact metrics and publication volume
Impact
- CiteScore 2026-06
- 0.1LetPub ·
- SJR 2026-06
- 0.11LetPub ·
- SNIP 2026-06
- 0.05LetPub ·
- h-index
- 7OpenAlex ·
- i10-index
- 3OpenAlex ·
- 2-year mean citedness
- 0.13OpenAlex ·
- Share of gold OA articles
- 0%LetPub ·
Articles by year OpenAlex count · 1,810 in total · the current year is incomplete
| Year | Articles | Open access | Citations |
|---|---|---|---|
| 2026 | 61 | 0 | 30 |
| 2025 | 76 | 0 | 41 |
| 2024 | 75 | 0 | 37 |
| 2023 | 74 | 0 | 18 |
| 2022 | 68 | 0 | 48 |
| 2021 | 65 | 2 | 22 |
Sources count differently and were observed at different times, so each source's own value is kept; "publisher" marks figures from the journal's website.
Fees & open access
APC and open-access policy
A subscription journal: articles are read by subscription or purchase, and authors usually pay no publication charge.
No source has fee information yet; check the journal's website.
The journal's website is authoritative for fees; sources were observed at different times and each keeps its own value, without averaging.
Profile
Publication details and official links
- Publisher
- Dustri-Verlag Dr. Karl Feistle
- ISSN
- 0341-3055
FAQ
Frequently asked questions about Atemwegs- und Lungenkrankheiten
Which databases index Atemwegs- und Lungenkrankheiten?
According to LetPub and DOAJ records, Atemwegs- und Lungenkrankheiten is indexed in Scopus.
Is Atemwegs- und Lungenkrankheiten open access, and what is the APC?
Atemwegs- und Lungenkrankheiten is a subscription journal. Fee information is not available yet; check the journal's website.
Sources and updates
The facts on this page come from LetPub, OpenAlex; every figure is tagged with its source and the date it was observed, and conflicting values are kept per source. LetPub source page: view ↗ (archived 2026-08-26). Last updated: .